Co-founder & CEO
Driven by a passion for pushing the boundaries of technology, David's expertise spans from basic science to business development. During his PhD, he characterized how protein receptors form complex structures that allow them to alter cell behavior. This knowledge was a critical building block for Modulari-T.
Co-founder & COO
Stephanie holds a PhD in Chemical Engineering from McGill University. Her technical background is focused on synthetic biology, advanced 3D cell culture systems, and biomaterials in the context of the cellular cancer microenvironment. Stephanie is fascinated by innovations in cell-based therapies and the scale up of their manufacturing.
Co-founder & CSO
Étienne completed his post-doc at the Dana-Farber Cancer Institute, where his work helped redefine the resting state of immune receptors (the TCR) and the steps required for proper activation.
He is currently a professor at the Institute for Research in Immunology and Cancer where his lab focuses on molecular and translation immunology in the field of oncology.
Principal Scientist
Delphine hold's a PhD in Immunology from INSERM, where she worked with TxCell (acq. Sangamo). Her post-doc studies at the University of Montreal focused on developing NK cell therapies.
President & CEO Interius Bio
Head of Cell Therapy Sanofi
Copyright © 2024 Modulari-T Biosciences - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.